260 related articles for article (PubMed ID: 8438615)
1. Strategies for development of potential candidate Shigella vaccines.
Lindberg AA; Pál T
Vaccine; 1993; 11(2):168-79. PubMed ID: 8438615
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis and immunology in shigellosis: applications for vaccine development.
Hale TL; Keren DF
Curr Top Microbiol Immunol; 1992; 180():117-37. PubMed ID: 1380415
[No Abstract] [Full Text] [Related]
3. An update on Shigella vaccines.
Ashkenazi S; Cohen D
Isr J Med Sci; 1994; 30(5-6):495-7. PubMed ID: 8034510
[TBL] [Abstract][Full Text] [Related]
4. Genetic determinants of virulence in Shigella and dysenteric strains of Escherichia coli: their involvement in the pathogenesis of dysentery.
Kopecko DJ; Baron LS; Buysse J
Curr Top Microbiol Immunol; 1985; 118():71-95. PubMed ID: 2414072
[No Abstract] [Full Text] [Related]
5. Antidysentery immunoprophylaxis in the light of current data about the pathogenicity of Shigella and the antidysentery immunity.
Meitert T
Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):195-230. PubMed ID: 6443688
[No Abstract] [Full Text] [Related]
6. Shigella vaccines.
Formal SB; Hale TL; Kapfer C
Rev Infect Dis; 1989; 11 Suppl 3():S547-51. PubMed ID: 2669098
[TBL] [Abstract][Full Text] [Related]
7. Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectors.
Levine MM; Galen J; Barry E; Noriega F; Tacket C; Sztein M; Chatfield S; Dougan G; Losonsky G; Kotloff K
Behring Inst Mitt; 1997 Feb; (98):120-3. PubMed ID: 9382732
[No Abstract] [Full Text] [Related]
8. Live attenuated Shigella flexneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery.
Phalipon A; Sansonetti P
Biologicals; 1995 Jun; 23(2):125-34. PubMed ID: 7546655
[TBL] [Abstract][Full Text] [Related]
9. Immunization of Mice with a Live Transconjugant Shigella Hybrid Strain Induced Th1 and Th17 Cell-Mediated Immune Responses and Confirmed Passive Protection Against Heterologous Shigellae.
Nag D; Koley H; Sinha R; Mukherjee P; Sarkar C; Withey JH; Gachhui R
Scand J Immunol; 2016 Feb; 83(2):92-101. PubMed ID: 26478541
[TBL] [Abstract][Full Text] [Related]
10. [The pathogenicity factors of Shigella studied as the bases for the design of diagnostic and prophylactic preparations].
Bondarenko VM
Zh Mikrobiol Epidemiol Immunobiol; 1996; (3):29-34. PubMed ID: 8771725
[TBL] [Abstract][Full Text] [Related]
11. Development and administration of live Shigella vaccines.
Pencu E
Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):231-50. PubMed ID: 6443689
[No Abstract] [Full Text] [Related]
12. Immunogenic Potency of a Chimeric Protein Comprising InvH and IpaD against Salmonella and Shigella spp.
Emami Mahmoudabadi FS; Vakili A; Nazarian S; Amani J; Mousavi Gargari SL
Iran J Allergy Asthma Immunol; 2021 Aug; 20(4):484-493. PubMed ID: 34418902
[TBL] [Abstract][Full Text] [Related]
13. Milk secretory IgA related to Shigella virulence antigens.
Cleary TG; Hyani K; Winsor DK; Ruiz-Palacios G
Adv Exp Med Biol; 1991; 310():369-73. PubMed ID: 1809012
[TBL] [Abstract][Full Text] [Related]
14. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
15. Current aspects of Shigella pathogenesis.
Torres AG
Rev Latinoam Microbiol; 2004; 46(3-4):89-97. PubMed ID: 17061529
[TBL] [Abstract][Full Text] [Related]
16. Oral immunization of monkeys with polyvalent dysentery vaccine.
Dhikidze EK; Kavtaradze KN; Krilova RI; Rauss K; Kétyi I; Vertényi A
Acta Microbiol Acad Sci Hung; 1977; 24(1):7-12. PubMed ID: 412396
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetics of virulence in Shigella.
Binns MM
Microbiol Sci; 1985 Sep; 2(9):275-8. PubMed ID: 2484669
[TBL] [Abstract][Full Text] [Related]
18. Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.
Levine MM; Kotloff KL; Barry EM; Pasetti MF; Sztein MB
Nat Rev Microbiol; 2007 Jul; 5(7):540-53. PubMed ID: 17558427
[TBL] [Abstract][Full Text] [Related]
19. Cross-protection provided by live Shigella mutants lacking major antigens.
Szijártó V; Hunyadi-Gulyás E; Emődy L; Pál T; Nagy G
Int J Med Microbiol; 2013 May; 303(4):167-75. PubMed ID: 23567193
[TBL] [Abstract][Full Text] [Related]
20. Genetics of virulence in Shigella.
Hale TL; Formal SB
Microb Pathog; 1986 Dec; 1(6):511-8. PubMed ID: 3334157
[No Abstract] [Full Text] [Related]
[Next] [New Search]
